Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
Cardiovascular Diseases | 0.830 | 1.000 | 5 | 2011 | 2019 | |||||||
|
0.851 | 0.240 | 11 | 61828092 | intron variant | C/T | snv | 0.11 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.810 | 1.000 | 4 | 2009 | 2019 | |||||||
|
0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 |
|
0.800 | 1.000 | 7 | 2010 | 2019 | ||||||||
|
0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 |
|
0.800 | 1.000 | 7 | 2008 | 2019 | ||||||||
|
0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 |
|
0.800 | 1.000 | 6 | 2009 | 2019 | ||||||||
|
0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 |
|
0.800 | 1.000 | 4 | 2010 | 2019 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 4 | 2009 | 2019 | ||||||||
|
0.925 | 0.160 | 11 | 61804006 | 5 prime UTR variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 4 | 2010 | 2015 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 3 | 2009 | 2019 | ||||||||
|
0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv |
|
0.800 | 1.000 | 3 | 2010 | 2019 | |||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 2 | 2011 | 2016 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 2 | 2012 | 2016 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 2 | 2011 | 2016 | ||||||||
|
0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv |
|
0.800 | 1.000 | 2 | 2010 | 2012 | |||||||||
|
0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv |
|
0.800 | 1.000 | 2 | 2012 | 2019 | |||||||||
|
0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 |
|
Nutritional and Metabolic Diseases | 0.800 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.851 | 0.240 | 11 | 61803910 | 5 prime UTR variant | G/A | snv | 0.26 |
|
0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.160 | 11 | 61804006 | 5 prime UTR variant | T/C | snv | 0.28 |
|
0.800 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.710 | 1.000 | 2 | 2011 | 2017 | ||||||||
|
0.925 | 0.120 | 11 | 61822009 | intron variant | A/C;G | snv |
|
Mental Disorders | 0.710 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
11 | 61806212 | 5 prime UTR variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 4 | 2018 | 2019 | ||||||||||
|
0.807 | 0.200 | 11 | 61802358 | 3 prime UTR variant | C/T | snv | 0.28 |
|
0.700 | 1.000 | 3 | 2009 | 2013 | ||||||||
|
0.742 | 0.240 | 11 | 61803311 | intron variant | T/C | snv | 0.28 |
|
0.700 | 1.000 | 3 | 2016 | 2019 | ||||||||
|
0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv |
|
0.700 | 1.000 | 3 | 2008 | 2013 |